Refractory seizures associated with an organic aciduria in a dog

Journal of the American Animal Hospital Association

Volumn 43, Issue 3, 2007, Pages 163-167

  Platt, Simon ^a   McGrotty, Yvonne L ^b   Abramson, Carley J ^c   Jakobs, Cornelis ^d  

^a UNIVERSITY OF GEORGIA   (United States)

^b BROADLEYS VETERINARY HOSPITAL   (United Kingdom)

^c OHIO STATE UNIVERSITY   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

ACYLCARNITINE; ANTICONVULSIVE AGENT; BROMIDE; CARNITINE; DRUG DERIVATIVE; ETIRACETAM; GLYCINE; N CAPROYLGLYCINE; N-CAPROYLGLYCINE; PHENOBARBITAL; PIRACETAM; POTASSIUM BROMIDE; POTASSIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE REPORT; DOG; DOG DISEASE; DRUG COMBINATION; FATALITY; FEMALE; PATHOPHYSIOLOGY; SEIZURE; TREATMENT OUTCOME; URINE;

ANIMALS; ANTICONVULSANTS; BROMIDES; CARNITINE; DOG DISEASES; DOGS; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; GLYCINE; PHENOBARBITAL; PIRACETAM; POTASSIUM COMPOUNDS; SEIZURES; TREATMENT OUTCOME;

EID: 34249680729     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0430163     Document Type: Article

References (24)

1. Leach JP. Levetiracetam in the management of epilepsy. Hosp Med 2004;65:740-744.
2. Vigevano F. Levetiracetam in pediatrics. J Child Neurol 2005;20: 87-93.
3. Isoherranen N, Roeder M, Soback S, et al. Enantioselective analysis of levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection. J Chromatogr B Biomed Sci Appl 2000;745:325-332.
4. Isoherranen N, Yagen B, Soback S, et al. Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs. Epilepsia 2001;42:825-830.
5. Ogier de Baulny H, Saudubray JM. Branched-chain organic acidurias. Semin Neonatol 2002;7:65-74.
6. Wajner M, Latini A, Wyse AT, et al. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 2004;27:427-448.
7. Podell M, Shelton GD, Nyhan WL, et al. Methylmalonic and malonic aciduria in a dog with progressive encephalomyelopathy. Metab Brain Dis 1996;11:239-247.
8. O'Brien DP, Barshop BA, Faunt KK, et al. Malonic aciduria in Maltese dogs: normal methylmalonic acid concentrations and malonyl-CoA decarboxylase activity in fibroblasts. J Inherit Metab Dis 1999;22:883-890.
9. Abramson CJ, Platt SR, Jakobs C, et al. L-2-hydroxyglutaric aciduria in Staffordshire bull terriers. J Vet Intern Med 2003; 17: 551-556.
10. Saudubray JM, Ogier H, Bonnefont JP, et al. Clinical approach to inherited metabolic diseases in the neonatal period: a 20-year survey. J Inherit Metab Dis 1989;12 (Suppl 1):25-41.
11. Kabra M. Dietary management of inborn errors of metabolism. Indian J Pediatr 2002;69:421-426.
12. Tserng KY, Jin SJ, Kerr DS, et al. Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res 1990;31:763-771.
13. Shelton GD, Nyhan WL, Kass PH, et al. Analysis of organic acids, amino acids, and carnitine in dogs with lipid storage myopathy. Muscle Nerve 1998;21:1202-1205.
14. Vernez L, Hopfgartner G, Wenk M, et al. Determination of carnitine and acylcarnitines in urine by high-performance liquid chromatography-electrospray ionization ion trap tandem mass spectrometry. J Chromatogr A 2003;984:203-213.
15. Anderson GD, Acheampong AA, Levy RH. Interaction between valproate and branched-chain amino acid metabolism. Neurology 1994;44:742-744.
16. Rusbridge C, Knowler SP. Inheritance of occipital bone hypoplasia (Chiari type I malformation) in Cavalier King Charles spaniels. J Vet Intern Med 2004;18:673-678.
17. Dewey CW, Berg JM, Barone G, et al. Foramen magnum decompression for treatment of caudal occipital malformation syndrome in dogs. J Am Vet Med Assoc 2005;227:1270-1275.
18. Lu D, Lamb CR, Pfeiffer DU, et al. Neurological signs and results of magnetic resonance imaging in 40 cavalier King Charles spaniels with Chiari type 1-like malformations. Vet Rec 2003;153:260-263.
19. Elia M, Biondi R, Sofia V, et al. Seizures in Chiari I malformation: a clinical and electroencephalographic study. J Child Neurol 1999; 14:446-450.
20. Winter S, Birek L, Walker T, et al. Therapy of metabolic disorders with intravenous (IV) access ports and long term intravenous L-carnitine therapy. Southeast Asian J Trop Med Public Health 1999;30 (Suppl 2):152-153.
21. Leppik IE. Antiepileptic drugs in development: prospects for the near future. Epilepsia 1994;35 (Suppl 4):S29-40.
22. Rogawski MA, Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004;5:553-564.
23. Cramer JA, Fisher R, Ben-Menachem E, et al. New antiepileptic drugs: comparison of key clinical trials. Epilepsia 1999;40:590-600.
24. Steinberg M, Faissler D. Levetiracetam therapy for long term idiopathic epileptic dogs. In: Proceed Am Coll Vet Intern Med Forum, Minneapolism 2004;22:818-819.